Insider Transactions in Q4 2024 at Apogee Therapeutics, Inc. (APGE)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Mark C. Mc Kenna Director |
BUY
Open market or private purchase
|
Direct |
20,000
+44.23%
|
$980,000
$49.43 P/Share
|
|
Dec 11
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,540
-0.87%
|
$222,460
$49.31 P/Share
|
|
Dec 11
2024
|
Carl Dambkowski Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,815
+0.69%
|
$39,930
$22.86 P/Share
|
|
Dec 04
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.56%
|
$690,000
$46.84 P/Share
|
|
Dec 04
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,665
-2.49%
|
$306,590
$46.07 P/Share
|
|
Nov 06
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.55%
|
$885,000
$59.55 P/Share
|
|
Nov 06
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,665
-1.22%
|
$393,235
$59.43 P/Share
|
|
Oct 02
2024
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-1.44%
|
$2,240,000
$56.41 P/Share
|
|
Oct 02
2024
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,665
-1.19%
|
$373,240
$56.51 P/Share
|